Published in Surgery on January 01, 2004
Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci (2010) 3.72
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology (2009) 2.78
Nonalcoholic fatty liver disease. CMAJ (2005) 2.56
Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology (2011) 1.80
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70
Treatment of non-alcoholic fatty liver disease. Postgrad Med J (2006) 1.63
Benefits of lifestyle modification in NAFLD. Gut (2007) 1.59
Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. Semin Liver Dis (2014) 1.56
Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol (2010) 1.11
The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr (2009) 1.03
Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes (2013) 1.01
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci (2014) 1.00
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. J Clin Transl Hepatol (2015) 0.95
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93
Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. Ann Surg (2010) 0.91
Changes in obesity-related diseases and biochemical variables after laparoscopic sleeve gastrectomy: a two-year follow-up study. BMC Surg (2014) 0.90
Reversal of liver fibrosis. Saudi J Gastroenterol (2009) 0.90
Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne) (2014) 0.88
Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr Gerontol Geriatr Res (2011) 0.86
Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol (2012) 0.84
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med (2011) 0.83
Gastrointestinal changes after bariatric surgery. Diabetes Metab (2013) 0.81
Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance. Hepat Mon (2013) 0.79
Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol (2012) 0.79
Novel Pharmacotherapy Options for NASH. Dig Dis Sci (2016) 0.78
Resistin expression correlates with steatohepatitis in morbidly obese patients. Surg Endosc (2012) 0.78
The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review. Diabetes Metab Syndr Obes (2013) 0.77
Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. Hepat Med (2014) 0.77
Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. Aliment Pharmacol Ther (2016) 0.77
Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus. Exp Ther Med (2015) 0.77
A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol (2007) 0.77
Influences of gestational obesity on associations between genotypes and gene expression levels in offspring following maternal gastrointestinal bypass surgery for obesity. PLoS One (2015) 0.76
The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease. Can J Gastroenterol Hepatol (2016) 0.75
The effect of bariatric surgery on liver histology. Dig Dis Sci (2007) 0.75
Treating morbid obesity in cirrhosis: A quest of holy grail. World J Hepatol (2015) 0.75
The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process. Gastroenterol Hepatol (N Y) (2006) 0.75
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00
Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev (2013) 2.96
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res (2004) 2.33
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology (2004) 2.29
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab (2003) 2.06
Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation (2003) 2.06
High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology (2012) 2.01
Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics (2006) 2.00
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol (2006) 1.98
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes (2002) 1.87
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78
Body weight is a strong predictor of postural stability. Gait Posture (2006) 1.76
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68
Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol (2012) 1.65
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. J Am Coll Cardiol (2008) 1.64
Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci (2009) 1.61
Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis (2011) 1.55
Intra-abdominal pressure in the morbidly obese. Obes Surg (2005) 1.47
Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen's test in 1010 patients. Am Heart J (2004) 1.47
Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46
Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg (2004) 1.45
Long-term experience with duodenal switch in adolescents. Obes Surg (2010) 1.44
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
Impact of bariatric surgery--induced weight loss on heart rate variability. Metabolism (2007) 1.43
Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index <50 kg/m2? Surg Obes Relat Dis (2010) 1.39
[Expected body mass index after bariatric surgery]. Cir Esp (2009) 1.39
Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci U S A (2013) 1.28
Retracted Metabolic basis of sexual dimorphism in PKU mice after genome-targeted PAH gene therapy. Mol Ther (2007) 1.25
Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver (2002) 1.23
Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation (2009) 1.12
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol (2010) 1.11
Duodenal switch: long-term results. Obes Surg (2007) 1.07
Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med (2005) 1.07
ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg (2007) 1.05
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation (2004) 1.05
Health-related quality of life in morbid obesity. Obes Surg (2006) 1.04
Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) (2009) 1.04
Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics (2010) 1.04
Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol (2012) 1.04
Regional differences in adipose tissue metabolism in obese men. Metabolism (2007) 1.03
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03
Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg (2006) 1.01
Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg (2004) 1.00
Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver Int (2005) 0.99
Outcome of pregnancies after biliopancreatic diversion. Obes Surg (2004) 0.98
Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol (2005) 0.97
Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects. Arterioscler Thromb Vasc Biol (2014) 0.96
Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals. Acta Diabetol (2008) 0.96
Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes (2002) 0.95
Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int (2006) 0.95
DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity (Silver Spring) (2010) 0.95
Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion. Obes Surg (2015) 0.92
Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids (2006) 0.92
Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver (2002) 0.92
Waist girth does not predict metabolic complications in severely obese men. Diabetes Care (2006) 0.92
Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis (2011) 0.91
Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients. J Obes (2013) 0.91
Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis (2008) 0.91